“To get healthcare’s powerful players to behave as desired, HHS and its various units are increasingly turning to the same playbook: naming and shaming bad actors.”
“Most recently, the CMS and the Office of the National Coordinator for Health Information Technology issued two proposed rules on Feb. 11 to spur interoperability and counter information-blocking…”
“The rules also took a less obvious swipe at electronic health record system vendors, who after years of effort have yet to achieve full interoperability. The proposed rule would require that vendors make patient information available in a standard, easily manipulated format. That would allow app vendors to…”
“The strategy of naming bad actors already has been used in the administration’s efforts to curb high drug prices. The CMS and the Food and Drug Administration have both sought to name drug companies that raise prices too high on Medicare or engage in anti-competitive tactics to deter generic-drug competition…” Read the full article here.
Source: Name and shame: HHS using disclosure, transparency to try to force change – By Robert King, February 16, 2019. Modern Healthcare.
